⚖️USITC Investigation 337-TA-1352 on Trade Secrets in Pharma
Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same; Notice of a Commission Determination To Review a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on Remedy, the Public Interest, and Bonding
Summary
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to review a final initial determination ("FID") issued by the presiding Chief Administrative Law Judge ("Chief ALJ"), finding a violation of section 337 of the Tariff Act of 1930, as amended. The Commission requests written submissions from the parties, interested government agencies, and other interested persons on the issues of remedy, the public interest, and bonding, under the schedule set forth below.
Agencies
- International Trade Commission
Business Impact
$$$ - High
The content involves a regulatory investigation regarding the misappropriation of trade secrets in the importation and sale of certain pharmaceutical products, which may lead to exclusion orders affecting specific businesses. This impacts compliance obligations, potential sanctions, and the competitive landscape for companies involved in biotechnology.